journal article·2021-04

pH/ATP cascade-responsive nano-courier with efficient tumor targeting and siRNA unloading for photothermal-immunotherapy

Xian Tang, Qinglin Sheng, Chaoqun Xu, Man Li, Jingdong Rao, Xuhui Wang, Yang Long, Yuan Tao, Xuan He, Zhirong Zhang, Qin He

Nano Today· Volume 37
Publisher page

Abstract

Abstract Tumor delivery of programmed death-ligand 1 (PD-L1) siRNA is promising to enhance photothermal therapy (PTT) caused anti-tumor immunity. However, the poor tumor targeting efficiency and insufficient gene release in tumor cells restrict curative effect. Herein, phenylboronic acid (PBA)-based tumor targeting and rapid gene release nano-courier is constructed by encapsulating PD-L1 siRNA (siP) and IR780 (a photothermal agent) in pH/ATP cascade-responsive micelle. The nano-courier can be detached long-circulating PEG shell in a weakly acidic tumor microenvironment, resulting in increased positive charge and PBA exposure for facilitating the penetration and uptake of nano-courier against tumors with overexpressed sialic acid (SA) residues. Subsequently, the intracellular ATP binding with PBA reducing the positive charge of nano-courier could effectively trigger rapid uploading of siP into cytosol. Both in vitro and in vivo studies proved the nano-courier has good performance on PD-L1 silencing on tumor cells. PTT with systemic antitumor immune responses triggered by efficient PD-L1 silencing completely ablated 4T1 orthotopic tumor, suppressed distant tumors growth and metastasis as well as reduced the tumor recurrence.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Near-infrared-light-activatable nanomaterial-mediated phototheranostic nanomedicines: an emerging paradigm for cancer treatment10.1002/adma.201706320 ↗
2. Activating antitumor immunity and antimetastatic effect through polydopamine‐encapsulated core–shell upconversion nanoparticles10.1002/adma.201905825 ↗
3. Size/charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration10.1002/adfm.201707249 ↗
4. Activating antitumor immunity and antimetastatic effect through polydopamine‐encapsulated core–shell upconversion nanoparticles10.1002/adma.201905825 ↗
5. Tumor‐targeted drug and CpG delivery system for phototherapy and docetaxel‐enhanced immunotherapy with polarization toward M1‐type macrophages on triple negative breast cancers10.1002/adma.201904997 ↗
6. Regulation and function of the PD-L1 checkpoint10.1016/j.immuni.2018.03.014 ↗
7. Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance10.1038/nature25015 ↗
8. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity10.1038/ncomms12632 ↗
9. Palmitoylation stabilizes PD-L1 to promote breast tumor growth10.1038/s41422-018-0124-5 ↗
10. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
11. Factors affecting the clearance and biodistribution of polymeric nanoparticles10.1021/mp800051m ↗
12. Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery10.1002/adma.201903637 ↗
13. A reduction and pH dual-sensitive polymeric vector for long-circulating and tumor-targeted siRNA delivery10.1002/adma.201403877 ↗
14. Tumor-microenvironment-adaptive nanoparticles codeliver paclitaxel and siRNA to inhibit growth and lung metastasis of breast cancer10.1002/adfm.201601703 ↗
15. Tumor acidity-sensitive polymeric vector for active targeted siRNA delivery10.1021/jacs.5b09602 ↗
16. Charge and assembly reversible micelles fueled by intracellular ATP for improved siRNA transfection10.1021/acsami.8b13300 ↗
17. Near-infrared light-responsive intracellular drug and siRNA release using Au nanoensembles with oligonucleotide-capped silica shell10.1002/adma.201200785 ↗
18. Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment
19. Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy10.1016/j.biomaterials.2015.10.022 ↗
20. Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors10.1021/ja406406h ↗
21. Biomolecular robotics for chemomechanically driven guest delivery fuelled by intracellular ATP10.1038/nchem.1681 ↗
22. Enhanced melanoma-targeted therapy by “Fru-Blocked” phenyboronic acid-modified multiphase antimetastatic micellar nanoparticles
23. Systemic siRNA delivery with a dual pH-responsive and tumor-targeted nanovector for inhibiting tumor growth and spontaneous metastasis in orthotopic murine model of breast carcinoma10.7150/thno.16855 ↗
24. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy10.1038/s41565-019-0485-z ↗
25. ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy10.7150/thno.26889 ↗
26. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
27. Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy10.2147/IJN.S106073 ↗
28. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy10.1039/C8NR01184B ↗
29. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting10.1016/j.biomaterials.2014.02.031 ↗
30. Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration10.1016/j.addr.2017.07.021 ↗
31. Physiological concentrations of purines and pyrimidines10.1007/BF00928361 ↗
32. ATP-triggered anticancer drug delivery10.1038/ncomms4364 ↗
33. Live cell imaging of duplex siRNA intracellular trafficking10.1093/nar/gkv307 ↗
34. Enhanced intracellular delivery of siRNA by controlling ATP‐responsivity of phenylboronic acid‐functionalized polyion complex micelles
35. Nanoparticles - a review10.4314/tjpr.v5i1.14634 ↗
36. Progress of drug-loaded polymeric micelles into clinical studies10.1016/j.jconrel.2014.06.042 ↗
37. Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel10.1016/j.biomaterials.2015.01.049 ↗
38. Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation10.1080/02656730500271692 ↗
39. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer10.1038/s41467-018-03473-9 ↗
40. Photosensitizer micelles together with IDO inhibitor enhance cancer photothermal therapy and immunotherapy
41. The two faces of interferon-γ in cancer10.1158/1078-0432.CCR-11-0482 ↗
42. Enhanced tumor retention effect by click chemistry for improved cancer immunochemotherapy10.1021/acsami.8b02954 ↗
43. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy10.1038/ncomms13193 ↗
44. Lineage relationship and protective immunity of memory CD8 T cell subsets10.1038/ni889 ↗
45. PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment10.1016/j.ejps.2018.10.021 ↗